![]() |
市場調查報告書
商品編碼
1819897
2025-2033 年消融設備市場報告(按設備技術、應用、最終用戶和地區)Ablation Devices Market Report by Device Technology, Application, End User, and Region 2025-2033 |
2024年,全球消融設備市場規模達65億美元。展望未來, IMARC Group預計到2033年,市場規模將達到155億美元,2025-2033年期間的複合年成長率(CAGR)為9.7%。危及生命的疾病日益流行,電生理學在切除異常組織方面的廣泛應用,以及配備機器人導航系統的下一代消融設備的開發,是推動市場發展的一些關鍵因素。
消融器械是用於各種醫療程序的醫療器械或工具,用於切除或破壞組織,通常用於治療或控制某些疾病。這些器械的工作原理是將熱能、冷能或射頻等能量輸送到目標組織,從而切除或改變組織。消融手術創傷小,通常比傳統手術更受歡迎,因為它們通常疼痛更少、恢復時間更短,並能降低併發症風險。
市場正經歷由幾個關鍵因素驅動的成長,包括癌症、心房顫動和慢性靜脈功能不全 (CVI) 等危及生命的疾病的盛行率不斷上升。疾病發生率的上升凸顯了對有效消融手術的需求。此外,大眾對微創消融技術可用性的認知不斷提高,這推動了市場擴張。這些手術具有許多優勢,包括減輕疼痛、最小疤痕、減少不適和加快患者康復時間。此外,透過移除異常組織來解決心律不整和心律不整的電生理手術的廣泛採用,也對市場成長做出了重大貢獻。此外,製造商還在響應不斷變化的醫療需求,透過創建非熱、非腫脹和非硬化的靜脈內消融設備來有效治療淺靜脈逆流。
危及生命的疾病日益流行
癌症仍然是全球主要死因之一,近年來發病率不斷上升。消融手術,尤其是在腫瘤學領域,作為外科手術的微創替代方案,已逐漸受到重視。它們被用來破壞肝臟、腎臟和肺部等各種器官的癌症組織。此外,靜脈內靜脈血栓形成 (CVI) 是指腿部靜脈無法充分將血液回流至心臟,導致疼痛、腫脹和皮膚改變的疾病。目前,靜脈內消融手術通常透過關閉功能障礙的靜脈來治療 CVI。 CVI 發病率的上升通常與生活方式和老化有關,這推動了對靜脈治療消融設備的需求。
電生理學的廣泛應用
電生理學是心臟病學的一個分支,研究心臟的電活動。由於其在診斷和治療各種心律不整(包括心房顫動)方面的有效性,該學科的應用範圍正在迅速擴大。電生理導引的消融手術需要精確定位並消除心臟中異常電訊號的來源。這種方法已成為許多心律不整的標準治療方法,為患者緩解症狀、改善生活品質提供了機會。此外,隨著醫療保健專業人員日益認知到電生理引導消融的益處,其應用也日益廣泛,從而導致對相關消融器械和設備的需求不斷成長。
下一代消融設備與機器人導航系統的整合
消融設備領域的技術進步是重要的驅動力。下一代消融設備整合了機器人導航系統,可提高精準度、準確性和手術效果。機器人輔助消融可以實現更可控、更精準的組織消融,從而降低併發症風險並改善患者預後。這些機器人系統提供治療區域的即時成像和映射,使醫護人員能夠更自信地導航複雜的解剖結構。因此,這些先進消融設備的採用率正在上升,尤其是在尋求提供一流治療方案的醫療機構中。提高病患安全性和手術成功率的前景進一步刺激了對這些設備的需求。
The global ablation devices market size reached USD 6.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.5 Billion by 2033, exhibiting a growth rate (CAGR) of 9.7% during 2025-2033. The increasing prevalence of life-threatening diseases, the widespread adoption of electrophysiology to remove abnormal tissues, and the development of next-generation ablation devices with robotic navigation systems represent some of the key factors driving the market.
Ablation devices are medical instruments or tools used in various medical procedures to remove or destroy tissue, typically with the goal of treating or managing certain medical conditions. These devices work by delivering energy, such as heat, cold, or radiofrequency, to the targeted tissue, causing its removal or alteration. Ablation procedures are minimally invasive and are often preferred over traditional surgical methods because they typically result in less pain, shorter recovery times, and reduced risk of complications.
The market is experiencing growth driven by several key factors, including the increasing prevalence of life-threatening diseases such as cancer, atrial fibrillation, and chronic venous insufficiency (CVI). This rise in disease incidence underscores the demand for effective ablation procedures. Furthermore, the growing awareness among the public about the availability of minimally invasive ablation techniques is propelling market expansion. These procedures offer numerous advantages, including reduced pain, minimal scarring, decreased discomfort, and quicker patient recovery times. Additionally, the widespread adoption of electrophysiology procedures to address irregular heart rhythms and cardiac arrhythmia by removing abnormal tissues is contributing significantly to market growth. Besides, manufacturers are also responding to evolving medical needs by creating non-thermal, non-tumescent, and non-sclerosant endovenous ablation devices tailored for the effective treatment of superficial vein reflux.
Increasing prevalence of life-threatening diseases
Cancer remains one of the leading causes of death worldwide, with a rising incidence in recent years. Ablation procedures, particularly in oncology, have gained prominence as minimally invasive alternatives to surgery. They are employed to destroy cancerous tissues in various organs, such as the liver, kidney, and lung. Moreover, CVI is a condition where veins in the legs fail to adequately return blood to the heart, leading to pain, swelling, and skin changes. Endovenous ablation procedures are now commonly used to treat CVI by closing off malfunctioning veins. The rising incidence of CVI, often associated with lifestyle factors and aging, has driven the demand for ablation devices designed for venous treatments.
Widespread adoption of electrophysiology
Electrophysiology is a branch of cardiology that deals with the electrical activity of the heart. It has witnessed a surge in adoption due to its effectiveness in diagnosing and treating various cardiac arrhythmias, including atrial fibrillation. Electrophysiology-guided ablation procedures involve precisely locating and eliminating the source of abnormal electrical signals in the heart. This approach has become the standard of care for many heart rhythm disorders, offering patients a chance for symptom relief and improved quality of life. Moreover, with healthcare professionals increasingly recognizing the benefits of electrophysiology-guided ablation, its adoption has become widespread, leading to a growing demand for related ablation devices and equipment.
Integration of next-generation ablation devices with robotic navigation systems
The advancement of technology in the field of ablation devices is a significant driving force. Next-generation ablation devices incorporate robotic navigation systems, which enhance precision, accuracy, and procedural outcomes. Robotic-assisted ablation allows for more controlled and targeted tissue ablation, reducing the risk of complications and improving patient outcomes. These robotic systems provide real-time imaging and mapping of the treatment area, enabling healthcare providers to navigate complex anatomical structures with greater confidence. As a result, the adoption of these advanced ablation devices is on the rise, particularly among healthcare facilities looking to offer state-of-the-art treatment options. The promise of improved patient safety and procedural success rates further fuels the demand for these devices.
Radiofrequency devices represent the most used device technology
RF ablation has demonstrated effectiveness across a wide range of medical applications. It is used to treat conditions such as cardiac arrhythmias (e.g., atrial fibrillation), liver tumors, kidney tumors, and chronic pain management. This versatility makes RF technology a go-to choice for physicians dealing with various medical specialties. Moreover, RF ablation has a long history of safe and successful use in medical procedures. The technology has been refined over the years, and clinicians have extensive experience with its application. This track record of safety and efficacy instills confidence in both healthcare providers and patients.
Cancer treatment holds the largest market share
Cancer is a widespread and prevalent disease that affects millions of people globally. It can occur in various organs and tissues, leading to a high demand for effective treatment options. As the incidence of cancer continues to rise due to factors like aging populations and lifestyle changes, the need for cancer treatment methods, including ablation, remains significant. Moreover, ablation techniques have proven to be versatile in the field of oncology. These procedures can be used to treat both primary tumors and metastatic lesions, making them applicable across different stages and types of cancer. Ablation can be employed in various organs, such as the liver, kidney, lung, and bone, providing clinicians with a wide range of treatment options.
Hospitals accounts for majority of market share
Ablation procedures often require specialized equipment and trained medical professionals. Hospitals are well-equipped to handle complex medical interventions and have the necessary infrastructure, including operating rooms, imaging technology, and support staff, to perform these procedures safely and effectively. This makes hospitals the natural choice for patients seeking ablation treatments. Moreover, hospitals house a wide range of medical specialties, including cardiology, oncology, gastroenterology, urology, and more. Ablation devices are used across multiple medical disciplines to treat various conditions. Hospitals can offer a comprehensive suite of ablation services, making them a one-stop destination for patients with diverse medical needs.
North America exhibits a clear dominance in the market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America, particularly the United States and Canada, boasts a highly developed and advanced healthcare infrastructure. The region is home to world-renowned medical institutions, hospitals, and research centers. This advanced infrastructure provides a solid foundation for the adoption of cutting-edge medical technologies, including ablation devices. Moreover, the region has one of the highest healthcare expenditure rates in the world. This substantial investment in healthcare, both by governments and private entities, enables the procurement of state-of-the-art medical equipment, including ablation devices. It also supports research and development efforts in the healthcare sector, leading to innovation and product advancements.
The competitive landscape of the market is characterized by the presence of multiple players that include established brands, emerging startups, and specialty manufacturers. Presently, leading companies are allocating significant resources to research and development efforts to develop innovative and technologically advanced ablation devices. This includes the development of next-generation ablation systems with enhanced precision, safety features, and user-friendly interfaces. They are also expanding their product portfolios to offer a comprehensive range of ablation devices catering to various medical specialties and applications. This includes devices designed for cardiac ablation, oncology, pain management, gynecology, and more. Moreover, companies are expanding their reach into new geographical markets. This expansion involves obtaining regulatory approvals and certifications in different regions, establishing distribution networks, and adapting their products to meet specific regional requirements.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include: